June 19, 2018
Seattle Children’s has opened a pioneering chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory HER2-positive central nervous system (CNS) tumors where CAR T cells will be delivered directly into the brain.
March 28, 2018
Health care is becoming increasingly complex—and remarkable. Research is unlocking more and more secrets about the human body, and conditions that were at one time hopeless have hopeful prognoses today thanks to new therapies.
March 11, 2018
A trial is underway to evaluate the use of dual chimeric antigen receptor T-cell immunotherapy for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia.
February 6, 2018
In the future, fighting cancer may no longer mean grueling chemotherapy, but genetically altered immune systems that can be “remote controlled.”